Expoxidation Using Peroxygenases
US-2016369312-A1 · Dec 22, 2016 · US
US2022042061A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022042061-A1 |
| Application number | US-202017429459-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 11, 2020 |
| Priority date | Feb 11, 2019 |
| Publication date | Feb 10, 2022 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a recombinant microorganism which is modified to be capable of producing diosmin and hesperidin and to the use thereof for producing diosmin and/or hesperidin.
Opening claim text (preview).
1 - 32 . (canceled) 33 . A recombinant microorganism comprising: a heterologous nucleic acid sequence coding for a flavanone 7-O-beta-D-glucosyltransferase (UGT) which is capable of adding a glucose in position 7 of hesperetin and/or diosmetin; and a heterologous nucleic acid sequence coding for a 6″-O-rhamnosyltransferase (RhaT) which is capable of transferring a rhamnose into position 6 of the glucose of hesperetin-7-O-glucoside and/or diosmetin-7-O-glucoside; and a heterologous nucleic acid sequence coding for a UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase (RHM) which is capable of producing UDP-rhamnose. 34 . The microorganism as claimed in claim 33 , in which the flavanone 7-O-beta-D-glucosyltransferase is selected from the group consisting of SEQ ID NOs: 113, 115, 91, 93, 95, 97, 99 and 101 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having flavanone 7-O-beta-D-glucosyltransferase activity. 35 . The microorganism as claimed in claim 33 , in which the 6″-O-rhamnosyltransferase is selected from the group consisting of SEQ ID NOs: 103 and 105 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having 6″-O-rhamnosyltransferase activity. 36 . The microorganism as claimed in claim 33 , in which the UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase is selected from the group consisting of SEQ ID NOs: 107, 109 and 111 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase activity. 37 . The microorganism as claimed in claim 33 , in which the flavanone 7-O-beta-D-glucosyltransferase is selected from the group consisting of SEQ ID NOs: 113 and 95 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having flavanone 7-O-beta-D-glucosyltransferase activity; and the 6″-O-rhamnosyltransferase is selected from the group consisting of SEQ ID NO: 103 and polypeptides comprising a sequence having at least 60% sequence identity with this sequence and having 6″-O-rhamnosyltransferase activity; and the UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase is selected from the group consisting of SEQ ID NO: 107 and polypeptides comprising a sequence having at least 60% sequence identity with this sequence and having UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase activity. 38 . The microorganism as claimed in claim 33 , the microorganism also comprising: a heterologous nucleic acid sequence coding for a tyrosine ammonia lyase (TAL); a heterologous nucleic acid sequence coding for a 4-coumarin-CoA ligase (4CL); a heterologous nucleic acid sequence coding for a naringenin-chalcone synthase (CHS); and a heterologous nucleic acid sequence coding for a chalcone isomerase (CHI). 39 . The microorganism as claimed in claim 38 , characterized in that it comprises: a heterologous nucleic acid sequence coding for a tyrosine ammonia lyase (TAL) comprising a sequence selected from the group consisting of SEQ ID NOs: 41 and 39 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having tyrosine ammonia lyase activity; a heterologous nucleic acid sequence coding for a 4-coumaroyl-CoA ligase (4CL) comprising a sequence selected from the group consisting of SEQ ID NOs: 123, 125, 43, 45, 47 and 49 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having 4-coumarate-CoA ligase activity; a heterologous nucleic acid sequence coding for a chalcone synthase (CHS) comprising a sequence selected from the group consisting of SEQ ID NOs: 53, 51, 55 and 57 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having chalcone synthase activity; and a heterologous nucleic acid sequence coding for a chalcone isomerase (CHI) comprising a sequence selected from the group consisting of SEQ ID NOs: 61 and 59 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having chalcone isomerase activity. 40 . The microorganism as claimed in claim 33 , characterized in that it also comprises a heterologous nucleic acid sequence coding for a flavonoid 3′-monooxygenase (F3′H). 41 . The microorganism as claimed in claim 40 , characterized in that the microorganism comprises a heterologous nucleic acid sequence coding for a flavonoid 3′-monooxygenase (F3′H) comprising a sequence selected from the group consisting of SEQ ID NOs: 7, 1, 3, 5, 9, 11, 13, 15, 17, 19, 21 and 121 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having flavonoid 3′-monooxygenase activity. 42 . The microorganism as claimed in claim 33 , characterized in that it also comprises a heterologous nucleic acid sequence coding for an O-methyltransferase (OMT). 43 . The microorganism as claimed in claim 42 , characterized in that the microorganism comprises a heterologous nucleic acid sequence coding for an O-methyltransferase (OMT) comprising a sequence selected from the group consisting of SEQ ID NOs: 119, 117, 87 and 89 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having O-methyltransferase activity. 44 . The microorganism as claimed in claim 33 , also comprising: a heterologous nucleic acid sequence coding for a phenylalanine ammonia lyase (PAL) comprising a sequence selected from the group consisting of SEQ ID NOs: 63, 65 and 77 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having phenylalanine ammonia lyase activity; and a heterologous nucleic acid sequence coding for a cinnamate 4-hydroxylase (C4H) comprising a sequence selected from the group consisting of SEQ ID NOs: 67, 69 and 79 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having cinnamate 4-hydroxylase activity. 45 . The microorganism as claimed in claim 33 , also comprising a heterologous or endogenous nucleic acid sequence coding for a flavone synthase (FNS). 46 . The microorganism as claimed in claim 45 , characterized in that it comprises a heterologous nucleic acid sequence coding for a flavone synthase (FNS) comprising a sequence selected from the group consisting of SEQ ID NOs: 33, 35, 37, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157 and 159 and polypeptides comprising a sequence having at least 60% sequence identity with one of these sequences and having flavone synthase activity. 47 . The microorganism as claimed in claim 33 , also comprising: a heterologous nucleic acid sequence coding for a cytochrome P450 reductase (CPR); and/or a heterologous or endogenous nucleic acid sequence coding for an S-adenosylmethionine synthetase (SAMT). 48 . The microorganism as claimed in claim 47 , characterized in that the microorganism comprises a heterologous nucleic acid sequence coding for a cytochrome P450 reductase (CPR) comprising a sequence selected from the group consisting of SEQ ID NOs: 25, 23, 27, 29 and 31 and polypeptides compris
acting on CH-OH groups as donors (1.1) · CPC title
Hexosyltransferases (2.4.1) · CPC title
transferring alkyl or aryl groups other than methyl groups (2.5) · CPC title
Methionine adenosyltransferase (2.5.1.6), i.e. adenosylmethionine synthetase · CPC title
acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.